Literature DB >> 25908385

Association of TLR4 gene polymorphisms with sporadic Parkinson's disease in a Han Chinese population.

Jing Zhao1, Xun Han, Li Xue, Konghua Zhu, Hongxin Liu, Anmu Xie.   

Abstract

Parkinson's disease (PD) is considered as a multifactorial disorder involving complex interactions between genetic and environmental factors, while previous studies point to a pivotal role of neuroinflammation in the pathophysiology of PD. As a member of pattern recognition receptors, TLR4 plays an important role in the immune response and inflammatory responses. Growing evidences suggest that mutation of TLR4 gene may be connected with the development of PD. The objective of this study was to evaluate whether genetic polymorphisms of the TLR4 gene are associated with PD susceptibility. We genotyped three single-nucleotide polymorphisms of the TLR4 gene (rs1927911, rs1927914 and rs10116253) by polymerase chain reaction and restriction fragment length polymorphism (PCR-RFLP) in unrelated 380 PD patients and 380 healthy-matched controls. Our study revealed that rs1927914 C allele carriers and C allele were probably related to a decreased risk of PD (p = 0.032 and p = 0.028, respectively) as well as male PD (p = 0.034) and early-onset PD (EOPD) (p = 0.023). In addition, there were significant differences in genotype and allele distribution in male PD patients and its healthy-matched control subgroup (p = 0.035 and p = 0.012, respectively). For rs1927911 and rs10116253 polymorphisms, genotype or allele frequencies did not differ between groups. Our data suggest that the TLR4 gene might contribute to the risk of developing PD in Han Chinese and rs1927914 polymorphism may be a protective factor for sporadic PD, male PD and EOPD.

Entities:  

Mesh:

Year:  2015        PMID: 25908385     DOI: 10.1007/s10072-015-2227-9

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  29 in total

Review 1.  Signaling pathways downstream of pattern-recognition receptors and their cross talk.

Authors:  Myeong Sup Lee; Young-Joon Kim
Journal:  Annu Rev Biochem       Date:  2007       Impact factor: 23.643

Review 2.  Why neurodegenerative diseases are progressive: uncontrolled inflammation drives disease progression.

Authors:  Hui-Ming Gao; Jau-Shyong Hong
Journal:  Trends Immunol       Date:  2008-07-01       Impact factor: 16.687

Review 3.  Synuclein deposition and non-motor symptoms in Parkinson disease.

Authors:  Kurt A Jellinger
Journal:  J Neurol Sci       Date:  2011-05-12       Impact factor: 3.181

Review 4.  Neuroinflammation is a key player in Parkinson's disease and a prime target for therapy.

Authors:  Li Qian; Patrick M Flood; Jau-Shyong Hong
Journal:  J Neural Transm (Vienna)       Date:  2010-06-23       Impact factor: 3.575

5.  Parkinsonism: onset, progression and mortality.

Authors:  M M Hoehn; M D Yahr
Journal:  Neurology       Date:  1967-05       Impact factor: 9.910

Review 6.  Biological role of Toll-like receptor-4 in the brain.

Authors:  Teresa Trotta; Chiara Porro; Rosa Calvello; Maria Antonietta Panaro
Journal:  J Neuroimmunol       Date:  2014-02-04       Impact factor: 3.478

7.  Polymorphisms of the TLR4 gene and risk of gastric cancer.

Authors:  Lina Huang; Kexin Yuan; Jingjing Liu; Xiyun Ren; Xiaoqun Dong; Wenjing Tian; Yunhe Jia
Journal:  Gene       Date:  2013-12-21       Impact factor: 3.688

8.  Sequence variants of toll like receptor 4 and late-onset Alzheimer's disease.

Authors:  Yen-Ching Chen; Ping-Keung Yip; Yi-Ling Huang; Yu Sun; Li-Li Wen; Yi-Min Chu; Ta-Fu Chen
Journal:  PLoS One       Date:  2012-12-18       Impact factor: 3.240

9.  Genetic variation of TLR-4, TLR-9 and TIRAP genes in Iranian malaria patients.

Authors:  Sedigheh Zakeri; Sakineh Pirahmadi; Akram A Mehrizi; Navid D Djadid
Journal:  Malar J       Date:  2011-04-04       Impact factor: 2.979

Review 10.  Ageing and Parkinson's disease: why is advancing age the biggest risk factor?

Authors:  Amy Reeve; Eve Simcox; Doug Turnbull
Journal:  Ageing Res Rev       Date:  2014-02-03       Impact factor: 10.895

View more
  14 in total

1.  Vinpocetine regulates levels of circulating TLRs in Parkinson's disease patients.

Authors:  Zhang Ping; Wu Xiaomu; Xie Xufang; Shao Liang
Journal:  Neurol Sci       Date:  2018-10-12       Impact factor: 3.307

Review 2.  Pathways to Parkinsonism Redux: convergent pathobiological mechanisms in genetics of Parkinson's disease.

Authors:  Ravindran Kumaran; Mark R Cookson
Journal:  Hum Mol Genet       Date:  2015-06-22       Impact factor: 6.150

Review 3.  The relevance of gender in Parkinson's disease: a review.

Authors:  Marina Picillo; Alessandra Nicoletti; Vincenza Fetoni; Barbara Garavaglia; Paolo Barone; Maria Teresa Pellecchia
Journal:  J Neurol       Date:  2017-01-04       Impact factor: 4.849

4.  Association of TLR4 gene polymorphisms with childhood Henoch-Schönlein purpura in a Chinese population.

Authors:  Hui Xu; Guizhen Jiang; Hongqiang Shen; Wei Li; Jianhua Mao; Yanxiang Pan
Journal:  Rheumatol Int       Date:  2017-09-13       Impact factor: 2.631

Review 5.  Possible Link between SARS-CoV-2 Infection and Parkinson's Disease: The Role of Toll-Like Receptor 4.

Authors:  Carmela Conte
Journal:  Int J Mol Sci       Date:  2021-07-01       Impact factor: 5.923

6.  Peripheral innate immune and bacterial signals relate to clinical heterogeneity in Parkinson's disease.

Authors:  Ruwani S Wijeyekoon; Deborah Kronenberg-Versteeg; Kirsten M Scott; Shaista Hayat; Wei-Li Kuan; Jonathan R Evans; David P Breen; Gemma Cummins; Joanne L Jones; Menna R Clatworthy; R Andres Floto; Roger A Barker; Caroline H Williams-Gray
Journal:  Brain Behav Immun       Date:  2020-01-30       Impact factor: 19.227

7.  Evidence for a role of adaptive immune response in the disease pathogenesis of the MPTP mouse model of Parkinson's disease.

Authors:  Heather L Martin; Matteo Santoro; Sarah Mustafa; Gernot Riedel; John V Forrester; Peter Teismann
Journal:  Glia       Date:  2015-10-29       Impact factor: 7.452

8.  The Inhibition of miR-873 Provides Therapeutic Benefit in a Lipopolysaccharide-Induced Neuroinflammatory Model of Parkinson's Disease.

Authors:  Jinhua Wu; Xuming Yu; Ke Xue; Juan Wu; Rongyan Wang; Xianfei Xie; Ke Li; Zheqiong Yang; Jiang Yue
Journal:  Oxid Med Cell Longev       Date:  2020-07-15       Impact factor: 6.543

9.  Associations of TLR4 gene polymorphisms with the risk of age-related macular degeneration in a Chinese Han population.

Authors:  Yu Ling; Fei Xiong
Journal:  Medicine (Baltimore)       Date:  2019-05       Impact factor: 1.817

10.  Association Between Toll-Like Receptor 4 (TLR4) and Triggering Receptor Expressed on Myeloid Cells 2 (TREM2) Genetic Variants and Clinical Progression of Huntington's Disease.

Authors:  Romina Vuono; Antonina Kouli; Emilie M Legault; Lauriane Chagnon; Kieren S Allinson; Alberto La Spada; Ida Biunno; Roger A Barker; Janelle Drouin-Ouellet
Journal:  Mov Disord       Date:  2019-11-14       Impact factor: 10.338

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.